Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

  1. Fust, K.
  2. Li, X.
  3. Maschio, M.
  4. Villa, G.
  5. Parthan, A.
  6. Barron, R.
  7. Weinstein, M.C.
  8. Somers, L.
  9. Hoefkens, C.
  10. Lyman, G.H.
Zeitschrift:
PharmacoEconomics

ISSN: 1179-2027,  1170-7690

Datum der Publikation: 2017

Ausgabe: 35

Nummer: 4

Seiten: 425-438

Art: Artikel

DOI: 10.1007/S40273-016-0474-0 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus